Search - tctmd.com

Presenter: Thomas J. Povsic, John P. Vavalle, Laura H. Aberle, Steven L. Zelenkofske, Roxana Mehran, Mauricio G. Cohen, Christopher E. Buller, Jan H. Cornel, Jaroslaw D. Kasprzak, Gilles Montalescot, Peter Fail, Ian J. Sarembock, John H. Alexander

January 03, 2012

Presentation TCT 2012

Evaluation of Dose Requirements for Prolonged Bivalirudin Administration in Patients with Renal Insufficiency and Suspected Heparin-Induced Thrombocytopenia.

Presenter: James W. Wisler, Jeffrey B. Washam, Richard C. Becker

January 03, 2012

Advertisement

Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

Jugular Angioplasty for MS May Improve Perceived Quality of Life

La Angioplastia Yugular para la EM podría Mejorar la Calidad de Vida Percibida

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Relación Hemorragia Intrahospitalaria/Mortalidad tras Sufrir un NSTEMI

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

HORIZONS-AMI: Las PCI mediante Acceso Radial Reducen las Hemorragias y los MACE en los STEMI

Sheath Size Associated with Radial Occlusion After Transradial PCI

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

El Tamaño de la Vaina se asocia a Oclusiones Radiales tras una PCI Transradial

El Patrón Re-estenótico tras Colocación de Stent Femoropoplíteo Predice la Recurrencia

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

Evaluation of Dose Requirements for Prolonged Bivalirudin Administration in Patients with Renal Insufficiency and Suspected Heparin-Induced Thrombocytopenia.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content